1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Notice of Special Interest (NOSI): Quantum Sensing in Biomedical Applications (SBIR/STTR) is sponsored by NIH National Center for Advancing Translational Sciences (NCATS) (Participating Institutes: NEI, NHLBI, NIBIB, NCATS, NCI). This NIH notice supports small businesses in developing and commercializing quantum technologies for biomedical applications, including tools and approaches for preventing, monitoring, and diagnosing disease.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Small U.S.-based businesses that develop quantum-based technologies. Small Business Concerns (SBCs) are encouraged to submit Phase I, Fast-Track, and Direct to Phase II SBIR, as well as Phase I and Fast-Track STTR grant applications. Confirm the full requirements in the official notice before applying.
Notice of Special Interest (NOSI): Quantum Sensing in Biomedical Applications (SBIR/STTR) is funded by NIH National Center for Advancing Translational Sciences (NCATS) (Participating Institutes: NEI, NHLBI, NIBIB, NCATS, NCI). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Five NHLBI Catalyze Product Definition RFAs — HL-26-016 through HL-26-020 — carry an October 21, 2026 receipt date, budget caps of $300,000 to $400,000 per year, and roughly 8 new awards annually. The science is not the gate. An Accelerator Partner and a 0.25:1 non-federal cost match are, and both take longer to line up than the nine weeks you have left.
Read articlePA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleAdvance from NIH SBIR Phase I to Phase II with tips on demonstrating feasibility, building a commercialization plan, and securing $1M in funding.
Read article